https://www.selleckchem.com/products/Compk.html
bability of mental and behavioral health conditions. Those assigned female at birth reporting female gender had the highest burdens. Side effects from the prolonged use of gonadotropin-releasing hormone (GnRH) agonists may lead to nonadherence to the treatment in men with advanced prostate cancer (PCa). We investigated the reasons contributing to nonadherence to GnRH agonists through interviews with men with PCa and focus groups with their health care professionals. The three stages of the study were validation of themes, interviews with
Like
Comment
Share
